Korro Bio is a biotechnology company focused on developing novel gene editing technologies to advance precision medicine and transform the treatment of genetic diseases. Founded in 2018, Korro Bio's innovative approaches have the potential to revolutionize the field of genetic medicine and bring about new therapeutic solutions for patients worldwide.

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b>Position&nbsp;Summary:&nbsp;</b>Korro Bio&nbsp;is&nbsp;seeking a&nbsp;passionate, self-motivated, and talented leader with a background in oligonucleotide therapeutics to join our Analytical Development team within CMC function. In this key role, you will be leading for all aspects of analytical development related to both drug substance and drug product components of the modalities. The successful candidate will be responsible for the&nbsp;deployment&nbsp;of methods for routine analysis&nbsp;of&nbsp;oligonucleotides&nbsp;to advance our RNA editing drug discovery&nbsp;platform and&nbsp;programs.&nbsp;The successful candidate will play a key role in advancing a pipeline of products from the early stage drug development to market approval. Success will require leadership across a matrixed analytical organization, effective collaboration with other CMC functions, close management of CDMO activities, and significant contribution to the overall CMC strategy for the program. Deep knowledge of cGMPs and regulatory guidelines, significant experience in the CMC development of oligonucleotide and considerable expertise in the analytical techniques and strategies commonly used in the development of oligonucleotides is essential. Candidate must express a high attention to details, be comfortable multitasking in a fast-paced startup environment.&nbsp; &nbsp;</div>

Director, Analytical Development

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><b style="font-size: 11pt;">Position Summary:</b><span style="font-size: 11pt;">&nbsp;​Korro Bio is&nbsp;seeking&nbsp;a highly motivated&nbsp;Associate&nbsp;Scientist&nbsp;to join our&nbsp;HTS-NGS operations team&nbsp;and work with an enthusiastic team of highly skilled scientists. The ideal candidate&nbsp;for this lab-based position&nbsp;is committed to&nbsp;delivering&nbsp;high quality results&nbsp;in a timely manner.&nbsp;This is an exciting opportunity to be part of a&nbsp;collaborative&nbsp;team and contribute to the development of next-generation RNA editing technology and therapeutics in a fast-paced biotech company.​</span><span style="font-size: 10.5pt;">&nbsp;</span></div>

Associate Scientist, HTS & NGS

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><span style="font-size: 10pt;"><b>Position Summary:&nbsp;&nbsp;</b></span></div><div><span style="font-size: 10pt;">The successful candidate will have a strong background leading early phase clinical trials. This individual will use outstanding cross-functional skills to achieve study and program goals and will develop a solid understanding of the clinical indications being pursued including knowledge of the patient needs, development plan, applicable regulatory guidance as well as the competitive landscape in the therapeutic space.</span></div>

Senior Manager, Clinical Operations

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div>Korro Bio is seeking a highly motivated Research Associate to join our In Vivo Pharmacology team. This is an exceptional opportunity to work alongside experienced scientists in a collaborative, cross-functional environment as we advance transformative genetic medicines to improve the lives of patients.</div>

(Contract) Research Associate, In Vivo Pharmacology

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><p style="margin: 0in; line-height: normal; font-size: 12pt; font-family: Aptos, sans-serif;"><span style="font-size: 10.0pt; font-family: Calibri, sans-serif;">Korro Bio is seeking a highly motivated Senior Associate Scientist to join our In Vivo Pharmacology team. This is an exceptional opportunity to work alongside experienced scientists in a collaborative, cross-functional environment as we advance transformative genetic medicines to improve the lives of patients.</span></p>

Senior Associate Scientist, In Vivo Pharmacology

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div><span style="font-size: 10pt;">Reporting to the Vice President, Clinical Development Operations, the Director, Clinical Data Management supports the Clinical Development organization by providing expertise in all aspects of clinical data management for assigned study(ies). The person in this role will participate with both strategic and hands-on support, oversight of vendors/CROs, and contributions to departmental process and standards development</span></div><div><span style="font-size: 10pt;">&nbsp;</span></div><div><span style="font-size: 10pt;">Excellent written and oral communication skills are required, as is the desire and ability to work in a small, fast-paced, and patient-focused environment.</span></div>

Director, Clinical Data Management

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div> <p>The Associate Director, Supply Chain Management will lead the strategic and operational management of complex clinical supply activities across all phases of development to provide life-changing therapeutics for patients. The position ensures the uninterrupted, compliant, and cost-effective delivery of investigational products to global clinical trial sites. The ideal candidate will bring deep expertise in supply chain strategy, vendor oversight, and cross-functional collaboration, with a strong understanding of GMP, IRT systems, and regulatory requirements.</p> <p>Excellent written and oral communication skills are required, as is the desire and ability to work in a small, fast-paced, and patient-focused environment.</p> </div>

Associate Director, Supply Chain Management

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div> <p>Korro Bio is seeking a passionate, driven, and creative Associate Scientist to join our oligonucleotide compound management team and work with an enthusiastic team of highly skilled scientists in a dynamic, growing company. The successful candidate will be responsible for handling, characterization, automation, storage and distribution of oligonucleotide compounds and work closely with cross functional team to advance our RNA editing drug discovery programs. The candidate will also be responsible for quantifying, performing purity analysis via HPLC/LCMS, and documenting results. The candidate will prepare samples and distribution of information to the downstream assay teams and pipelines. Additional responsibilities include cell screening and NGS work. Candidate must express a high attention to detail, be comfortable multitasking, oversee day to day operations and ability to function in an interdisciplinary and fast-paced startup environment.</p> </div>

Associate Scientist, Compound Management, Cell Screening & NGS

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div>

Senior Scientist, Computational Biology

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div>Korro Bio is seeking a highly motivated Associate Director or Director of Toxicology to lead the design and execution of nonclinical safety studies across our RNA editing portfolio. Reporting to the Senior Director, DMPK, this individual will be a key scientific and strategic contributor responsible for building and advancing Korro’s toxicology capabilities, with an emphasis on oligonucleotide-based therapeutics. The ideal candidate brings deep experience in nonclinical development, a collaborative mindset, and a passion for bringing novel genetic medicines to patients.</div>

Associate Director / Director, Toxicology

Research Associate, In Vivo Pharmacology

Director, CMC QA

Associate Director, Clinical Supply Chain Management

<div><b>Company Summary:</b>&nbsp;<span style="font-size: 11pt">Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro is expanding the reach of genetic medicines by delivering additional precision and tunability, which has the potential for increased specificity and improved long-term tolerability. Using an oligonucleotide-based approach, Korro expects to bring its medicines to patients by leveraging its proprietary platform with precedented delivery modalities, manufacturing know-how, and established regulatory pathways of approved oligonucleotide drugs. Korro is based in Cambridge, Massachusetts. </span></div><div><br></div><div><span style="font-size: 11pt">We are collaborative and united by a common mission. We are building a company with extraordinary people with an audacious vision to create transformative genetic medicines for prevalent diseases. Our values - </span><i style="font-size: 11pt">Rewrite the future, On the Cutting Edge, Better Together, Dynamically Different, Kindness and Integrity </i><span style="font-size: 11pt">form the fabric of the organization. They are reinforced daily and serve as key dimensions in the hiring process to help us ensure that Korro is a magnet for outstanding talent and a great place to work. Join us as we redefine what's possible in genetic medicine and work to make a lasting impact on human health.</span></div><div><br></div><div> <p>Korro Bio&nbsp;is&nbsp;seeking an experienced analytical scientist to join the growing CMC team. You will focus on management of CMO analytical labs as well as development of analytical methods, characterization of impurities, degradation pathways, and transfer, qualification/validation of analytical methods for synthetic oligonucleotide-based therapies. This role will support and manage - the quality and stability of drug substances and drug products throughout the development lifecycle. You will work closely with cross-functional teams and external partners to ensure that analytical data supports regulatory filings and clinical trial progression.</p> </div>

Get a job referral to Korro Bio

Description

Jobs· 10 open

About

Financials

Referrals

Your career is worth investing in.

Get unlimited referrals with Premium.